This suggests that the increased requirement for STAT3 signaling in tumor cells of KPT tumors, including the possible involvement of tumor cells that hitherto did not respond to IL-11, appears to be realized by the coordinated upregulation of IL-6 and its cognate IL-6Ra receptor subunit. The gene discussed is STAT3; the disease is neoplasm.